Keywords: aronex, atragen, set, filing, end-97, pharmaceuticals, presented

Aronex' Atragen Set For Filing End-97

Article | 07 April 1997

Aronex Pharmaceuticals has presented encouraging clinical data with itsnovel formulation of tretinoin, Atragen, in acute promyelocytic leukemia and Kaposi's sarcoma, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Genzyme

Go to company listing

Related Drugs

Atralin

Tretinoin

Vesanoid

Go to drug listing